Aquestive Therapeutics, Inc.AQSTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+64.4%
5Y CAGR+30.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+64.4%/yr
vs -18.1%/yr prior
5Y CAGR
+30.7%/yr
Recent acceleration
Acceleration
+82.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $121.17M | +69.4% |
| 2024 | $71.55M | +199.7% |
| 2023 | $23.87M | -12.5% |
| 2022 | $27.27M | -2.7% |
| 2021 | $28.02M | -11.9% |
| 2020 | $31.81M | -35.5% |
| 2019 | $49.33M | -18.6% |
| 2018 | $60.60M | +248.7% |
| 2017 | $17.38M | +88.7% |
| 2016 | $9.21M | - |